Textbook of Ocular Pharmacology

, by Zimmerman, Thom J., M.D.; Kooner, Karanjit; Sharir, Mordechai, M.D.; Fechtner, Robert D., M.D.

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

ISBN: 9780781703062 | 0781703069
Cover: Hardcover
Copyright: 9/1/1997

Rent

(Recommended)

$136.31

Term

Due

Price

Semester

Dec 13

$143.48

Quarter

Aug 16

$136.31

Short Term

Jul 3

$129.13

*This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.
Buy Used

Usually Ships in 2-4 Business Days

$146.27
Buy New

Usually Ships in 3-5 Business Days

$196.03

Summary

Supplemental Materials

Univ. of Louisville, KY. Extensive reference on the present and emerging knowledge of ocular pharmacology. For ophthalmologists and residents-in-training. 97 contributors, 92 U.S.

Section Editors

xiii

(4)

Contributing Authors

xvii

(10)

Preface

xxvii

(2)

Acknowledgments

xxix

Section I: General Ocular Pharmacology

(216)

Overview

(2)

Mordechai Sharir

1. The History of Ocular Pharmacology

(6)

Mordechai Sharir

2. Pharmacodynamics: Drug-Receptor Interactions

(26)

Frederick W. Benz

3. Drug Reactions Not Mediated via Receptors

(6)

Anat Loewenstein

Moshe Lazar

4. Cholinergics

(10)

Craig E. Crosson

5. Eicosanoid Receptors in Ocular Tissues

(10)

Parimal Bhattacherjee

6. Steroids in Ocular Therapy

(14)

Prasad S. Kulkarni

7. Adrenergic Pharmacology of the Anterior Segment

(20)

David E. Potter

Gary D. Novack

8. Immunosuppressive Therapy for Uveitis

(24)

Margaret K. L. Cheung

James T. Rosenbaum

9. Ocular Pharmacokinetics

119

(20)

Ronald D. Schoenwald

10. Basic Considerations of Ocular Drug-Delivery Systems

139

(12)

Amir Bar-Ilan

Ron Neumann

11. Development of New Drugs for Ophthalmology

151

(14)

Gary D. Novack

12. Ethical Issues in Ophthalmic Research

165

(6)

Mark P. Nasisse

13. The Ophthalmologist as Clinical Investigator

171

(8)

Gary D. Novack

14. Introduction to Toxicology

179

(8)

Harrell E. Hurst

15. Effect of Disease on Drug Disposition

187

(10)

Bruce A. Mueller

Steven R. Abel

16. Effect of Age on Drug Disposition

197

(8)

William F. Buss

Steven R. Abel

Bruce A. Mueller

17. Effect of Pregnancy on Drug Disposition

205

(12)

Helen Y. How

Joseph A. Spinnato

Section II: Glaucoma

217

(144)

Overview

217

(2)

Karanjit S. Kooner

Thom J. Zimmerman

18. Definitions and Classification of Glaucoma

219

(2)

Robert D. Fechtner

Karanjit S. Kooner

19. Direct, Indirect, and Dual-Action Parasympathetic Drugs

221

(18)

Paul L. Kaufman

B'Ann True Gabelt

20. Epinephrine and Dipivefrin

239

(8)

Ervin N. Fang

Michael A. Kass

21. Alpha-2 Agonists in Glaucoma Therapy

247

(8)

Mark S. Juzych

Alan L. Robin

Gary D. Novack

22. Thymoxamine (Alpha-Adrenergic Antagonist)

255

(6)

Karanjit S. Kooner

23. Beta-blockers

261

(16)

Mark S. Juzych

Thom J. Zimmerman

24. Oral Carbonic Anhydrase Inhibitors

277

(10)

Jeffrey G. Piper

25. Topical Carbonic Anhydrase Inhibitors

287

(4)

Mordechai Sharir

26. Hyperosmotic Agents

291

(6)

Kuldev Singh

Theodore Krupin

27. Antifibrosis Agents: Pharmacologic Inhibition of Wound Healing

297

(18)

Bruce C. Henderson

George F. Nardin

28. Prostaglandins and Prostaglandin Analogues

315

(14)

Carl B. Camras

Laszlo Z. Bito

Carol B. Toris

29. Future Role of Neuroprotective Agents in Glaucoma

329

(12)

Ozlem Evrem Abbasoglu

Karanjit S. Kooner

30. Medical Trabeculocanulotomy

341

(6)

R. Rand Allingham

31. Physiologic Aspects of Glaucoma and Its Current and Future Management

347

(14)

Laszlo Z. Bito

Section III: Retina

361

(110)

Overview

361

(2)

David V. Weinberg

Lee M. Jampol

32. Antibiotics and Antifungals

363

(24)

Travis A. Meredith

33. Antivirals in the Treatment of Retinal Diseases

387

(22)

Ramana S. Moorthy

David V. Weinberg

34. Pharmacologic Therapy for Cystoid Macular Edema

409

(8)

Lee M. Jampol

35. Proliferative Vitreoretinopathy: Biology and Pharmacology

417

(12)

Glenn J. Jaffe

P. Andrew Pearson

36. Drugs Affecting the Coagulation/Fibrinolysis Pathways

429

(14)

George A. Williams

37. Ocular Pharmacology of Diabetic Retinopathy

443

(4)

Lawrence I. Rand

38. Medical Therapy for Macular Degeneration

447

(8)

Johanna M. Seddon

Joan W. Miller

39. Angiogenesis and Growth Factors

455

(16)

Joan W. Miller

Patricia A. D'Amore

Section IV: Cornea and External Diseases

471

(210)

Overview

471

(2)

George R. John

Herbert E. Kaufman

40. Penicillins and Cephalosporins

473

(20)

Adam H. Kaufman

Jules Baum

41. Antiparasitic Agents

493

(14)

Lisa D. Kelly

42. The Tetracyclines

507

(8)

Carol L. Karp

Eduardo C. Alfonso

43. Erythromycin, Clarithromycin, and Azithromycin

515

(10)

Robert E. Leonard II

Carol L. Karp

Eduardo C. Alfonso

44. Chloramphenicol

525

(6)

Carol L. Karp

Joseph R. Gussler

Eduardo C. Alfonso

45. Aminoglycosides in Ophthalmology

531

(6)

Steven M. Patalano

Robert A. Hyndiuk

46. Fluoroquinolones

537

(12)

Gregory S. H. Ogawa

Robert A. Hyndiuk

47. Peptide Antibiotics: Vancomycin, Bacitracin, and Polymyxin B

549

(10)

Gerard D'Aversa

George A. Stern

48. Rifampin

559

(6)

W. Craig Fowler

James E. Arena

Mark J. Iacobucci

49. Amebic Disease of the Eye

565

(10)

Hassan Alizadeh

Jerry Niederkorn

James P. McCulley

50. Antivirals

575

(12)

James M. Hill

Richard J. O'Callaghan

Bryan M. Gebhardt

51. Pharmacotherapy of Fungus Infections of the Eye

587

(22)

Terrence P. O'Brien

Peter Rhee

52. Antiallergic Therapies

609

(26)

Mark B. Abelson

Paula J. McGarr

Kevin P. Richard

53. Intraocular Irrigating Solutions

635

(20)

Henry F. Edelhauser

Roger Amass

Richard Lambert

54. Surgical Viscoelastic Substances

655

(6)

Gavin J. Roberts

Robert A. Hyndiuk

55. Antiseptics and Disinfectants

661

(6)

Rajesh K. Rajpal

Stephen R. Glaser

56. Mitomycin Treatment of Corneal Disease

667

(4)

Roswell R. Pfister

57. Cyanoacrylate Tissue Adhesives

671

(4)

George R. John

58. Future Developments in Corneal Therapy: Growth Factors

675

(6)

Gregory Schultz

Section V: Uveitis

681

(82)

Overview

681

(2)

C. Stephen Foster

Albert Vitale

59. Pharmacology of Medical Therapy for Uveitis

683

(20)

Albert Vitale

C. Stephen Foster

60. Mydriatic and Cycloplegic Agents

703

(10)

Albert Vitale

C. Stephen Foster

61. Nonsteroidal Antiinflammatory Drugs

713

(10)

Albert Vitale

C. Stephen Foster

62. Immunosuppressive Chemotherapy

723

(40)

Albert Vitale

C. Stephen Foster

Section VI: Anesthesia

763

(18)

Overview

763

(2)

Martin A. Acquadro

63. Anesthetic and Perianesthetic Medications

765

(6)

Martin A. Acquadro

64. Anesthetic Considerations for Ophthalmic Surgery

771

(10)

Martin A. Acquadro

Section VII: Ocular Medications for Pediatric Patients

781

(24)

Overview

781

(2)

Forrest D. Ellis

65. Topical Ophthalmic Preparations Used for Infants and Children

783

(4)

Forrest D. Ellis

66. Cycloplegic Agents

787

(4)

Forrest D. Ellis

67. Topical and Local Anesthetic Agents

791

(4)

Forrest D. Ellis

68. Antiglaucoma Medications

795

(6)

Forrest D. Ellis

69. Ocular Antiinflammatory Agents

801

(4)

Forrest D. Ellis

Section VIII: Diagnostic Drugs

805

(60)

Overview by Carol F. Zimmerman

805

(2)

70. Mydriatic and Cycloplegic Drugs

807

(20)

Carol F. Zimmerman

R. Nick Hogan

Trang Diem Le

71. Drugs for the Diagnosis of Pupillary Disorders

827

(10)

Carol F. Zimmerman

72. Drugs for the Diagnosis and Treatment of Myasthenia Gravis

837

(12)

Gil I. Wolfe

Richard J. Barohn

Steven L. Galetta

73. Sodium Fluorescein and Other Tissue Dyes

849

(16)

R. Nick Hogan

Carol F. Zimmerman

Subject Index

865

Please wait while the item is added to your bag...

FREE SHIPPING

Amazon no longer offers textbook rentals. We do!

Textbook of Ocular Pharmacology

Summary

Table of Contents

Supplemental Materials